Detalhe da pesquisa
1.
Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment.
J Dtsch Dermatol Ges;
22(1): 34-42, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37926830
2.
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors.
Exp Dermatol;
32(12): 2187-2188, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36541075
3.
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real-life experience on 638 patients with psoriasis.
Exp Dermatol;
32(9): 1591-1594, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37395012
4.
Drug survival and efficacy of anti-interleukin 23 biologics in psoriasis: a comparative study on different agents.
Clin Exp Dermatol;
48(4): 379-381, 2023 03 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36745578
5.
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
Dermatol Ther;
35(11): e15818, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36097346
6.
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real-life experience in a tertiary referral centre.
Australas J Dermatol;
62(3): e431-e432, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34042171
7.
Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years.
Int J Dermatol;
2024 Jan 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38284277
8.
Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents.
Int J Dermatol;
2024 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38751026
9.
Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience.
J Clin Med;
12(24)2023 Dec 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38137572
10.
Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study.
Expert Opin Biol Ther;
23(9): 929-936, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37458181
11.
Seven Years of Culture Collection of Neisseria gonorrhoeae: Antimicrobial Resistance and Molecular Epidemiology.
Microb Drug Resist;
29(3): 85-95, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36757312
12.
Understanding Barriers Impacting upon Patient Wellbeing: A Nationwide Italian Survey and Expert Opinion of Dermatologists Treating Patients with Moderate-to-Severe Psoriasis.
J Clin Med;
13(1)2023 Dec 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38202108
13.
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.
J Dermatolog Treat;
33(4): 2352-2357, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34315331
14.
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing.
J Clin Med;
11(10)2022 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35628929
15.
Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study.
Eur J Dermatol;
21(2): 242-7, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21382788
16.
Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study.
Clin Rheumatol;
40(6): 2251-2262, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33155160
17.
Recurrent herpes labialis and Herpes simplex virus-1 genitalis: what is the link?
G Ital Dermatol Venereol;
154(5): 529-532, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28181784
18.
Time trend analysis (2009-2016) of antimicrobial susceptibility in Neisseria gonorrhoeae isolated in Italy following the introduction of the combined antimicrobial therapy.
PLoS One;
12(12): e0189484, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29240786